The potential role of COX-2/PGs signaling pathway in epileptogenesis and associated neuroinflammation: collusions or serendipity.

Saved in:
Bibliographic Details
Title: The potential role of COX-2/PGs signaling pathway in epileptogenesis and associated neuroinflammation: collusions or serendipity.
Authors: Alsfouk, Bshra A. (AUTHOR), Al-Kuraishy, Hayder M. (AUTHOR), Al-Gareeb, Ali I. (AUTHOR), Abdelaziz, Ahmed M. (AUTHOR), Ismail, Alaa (AUTHOR), Alkazmi, Luay M. (AUTHOR), Alexiou, Athanasios (AUTHOR), Papadakis, Marios (AUTHOR), El-Saber Batiha, Gaber (AUTHOR)
Source: Neurological Sciences. Feb2026, Vol. 47 Issue 2, p1-18. 18p.
Abstract: Background: Epilepsy is a neurological condition characterized by recurrent, spontaneous seizures stemming from sudden, abnormal synchronization of neuronal activity in specific brain regions, driven by structural or functional alterations. This disorder is preceded by epileptogenesis, a dynamic process marked by cellular and molecular changes that heighten brain excitability. Although anti-seizure medications (ASMs) remain the cornerstone of treatment, roughly 30% of patients develop refractory epilepsy, which resists ASMs therapy. Critically, ASMs do not prevent epileptogenesis, implying divergent mechanisms govern disease progression. Methods: This review evaluates the pathway’s contributions to neuroinflammation, epileptogenesis, and epilepsy, and explores the promise of COX-2 inhibitors in managing refractory epilepsy. Results: Epileptogenesis continues even after seizures manifest and is strongly associated with drug-resistant forms such as temporal lobe epilepsy (TLE). Neuroinflammation, which develops subsequent to the epileptic seizure, aggravates refractory epilepsy by enhancing the extrusion of ASMs across the blood-brain barrier (BBB), reducing their therapeutic efficacy. Following epileptic seizures, cyclooxygenase-2 (COX-2), a key enzyme in prostaglandin (PG) synthesis, is upregulated and activates the COX-2/PG pathway, leading to exacerbation of neuroinflammation and acceleration of epilepsy progression. Furthermore, by inducing neuronal hyperexcitability and epileptogenesis, elevated COX-2 and PG levels correlate with increased seizure severity and frequency. Conclusion: Consequently, targeting of the COX-2/PG axis has emerged as a potential therapeutic strategy. [ABSTRACT FROM AUTHOR]
Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 191283319
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The potential role of COX-2/PGs signaling pathway in epileptogenesis and associated neuroinflammation: collusions or serendipity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Alsfouk%2C+Bshra+A%2E%22">Alsfouk, Bshra A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al-Kuraishy%2C+Hayder+M%2E%22">Al-Kuraishy, Hayder M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al-Gareeb%2C+Ali+I%2E%22">Al-Gareeb, Ali I.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abdelaziz%2C+Ahmed+M%2E%22">Abdelaziz, Ahmed M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ismail%2C+Alaa%22">Ismail, Alaa</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alkazmi%2C+Luay+M%2E%22">Alkazmi, Luay M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alexiou%2C+Athanasios%22">Alexiou, Athanasios</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Papadakis%2C+Marios%22">Papadakis, Marios</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22El-Saber+Batiha%2C+Gaber%22">El-Saber Batiha, Gaber</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. Feb2026, Vol. 47 Issue 2, p1-18. 18p.
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: Epilepsy is a neurological condition characterized by recurrent, spontaneous seizures stemming from sudden, abnormal synchronization of neuronal activity in specific brain regions, driven by structural or functional alterations. This disorder is preceded by epileptogenesis, a dynamic process marked by cellular and molecular changes that heighten brain excitability. Although anti-seizure medications (ASMs) remain the cornerstone of treatment, roughly 30% of patients develop refractory epilepsy, which resists ASMs therapy. Critically, ASMs do not prevent epileptogenesis, implying divergent mechanisms govern disease progression. Methods: This review evaluates the pathway’s contributions to neuroinflammation, epileptogenesis, and epilepsy, and explores the promise of COX-2 inhibitors in managing refractory epilepsy. Results: Epileptogenesis continues even after seizures manifest and is strongly associated with drug-resistant forms such as temporal lobe epilepsy (TLE). Neuroinflammation, which develops subsequent to the epileptic seizure, aggravates refractory epilepsy by enhancing the extrusion of ASMs across the blood-brain barrier (BBB), reducing their therapeutic efficacy. Following epileptic seizures, cyclooxygenase-2 (COX-2), a key enzyme in prostaglandin (PG) synthesis, is upregulated and activates the COX-2/PG pathway, leading to exacerbation of neuroinflammation and acceleration of epilepsy progression. Furthermore, by inducing neuronal hyperexcitability and epileptogenesis, elevated COX-2 and PG levels correlate with increased seizure severity and frequency. Conclusion: Consequently, targeting of the COX-2/PG axis has emerged as a potential therapeutic strategy. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=191283319
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10072-025-08679-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 18
        StartPage: 1
    Titles:
      – TitleFull: The potential role of COX-2/PGs signaling pathway in epileptogenesis and associated neuroinflammation: collusions or serendipity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Alsfouk, Bshra A.
      – PersonEntity:
          Name:
            NameFull: Al-Kuraishy, Hayder M.
      – PersonEntity:
          Name:
            NameFull: Al-Gareeb, Ali I.
      – PersonEntity:
          Name:
            NameFull: Abdelaziz, Ahmed M.
      – PersonEntity:
          Name:
            NameFull: Ismail, Alaa
      – PersonEntity:
          Name:
            NameFull: Alkazmi, Luay M.
      – PersonEntity:
          Name:
            NameFull: Alexiou, Athanasios
      – PersonEntity:
          Name:
            NameFull: Papadakis, Marios
      – PersonEntity:
          Name:
            NameFull: El-Saber Batiha, Gaber
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 15901874
          Numbering:
            – Type: volume
              Value: 47
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Neurological Sciences
              Type: main
ResultId 1